Altfest L J & CO Inc Eli Lilly & CO Transaction History

Altfest L J & CO Inc

$751 Million
Q3 2024

A detailed history of Altfest L J & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Altfest L J & CO Inc holds 9,586 shares of LLY stock, worth $7.63 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

9,586

Previous 8,324 15.16%

Holding current value

$7.63 Million

Previous $7.54 Million 12.67%

% of portfolio

1.13%

Previous 1.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $974,440 - $1.21 Million	1,262 Added 15.16%	9,586 $8.49 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $257,328 - $322,709	355 Added 4.45%	8,324 $7.54 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $34,939 - $46,744	59 Added 0.75%	7,969 $6.2 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $166,485 - $196,264	-317 Reduced 3.85%	7,910 $4.61 Million
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $16,953 - $23,372	-39 Reduced 0.47%	8,227 $4.42 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $16,484 - $22,042	-47 Reduced 0.57%	8,266 $3.88 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $7,455 - $8,755	-24 Reduced 0.29%	8,313 $2.86 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $266,886 - $310,976	-830 Reduced 9.05%	8,337 $3.05 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $67,893 - $77,372	-229 Reduced 2.44%	9,167 $2.96 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $511,469 - $600,540	-1,835 Reduced 16.34%	9,396 $3.05 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $46,233 - $57,457	-197 Reduced 1.72%	11,231 $3.22 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $129,963 - $161,285	-578 Reduced 4.81%	11,428 $3.16 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $90,856 - $111,811	410 Added 3.54%	12,006 $2.77 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $96,955 - $125,410	537 Added 4.86%	11,596 $2.66 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $30,234 - $39,140	184 Added 1.69%	11,059 $2.07 Million
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $205,474 - $271,892	1,575 Added 16.94%	10,875 $1.84 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $49,276 - $56,996	-337 Reduced 3.5%	9,300 $1.38 Million
Q2 2020 Jul 21, 2020	BUY	$136.42 - $164.18 $111,455 - $134,135	817 Added 9.26%	9,637 $1.58 Million
Q1 2020 Apr 13, 2020	BUY	$119.05 - $147.35 $1,428 - $1,768	12 Added 0.14%	8,820 $1.22 Million
Q4 2019 Jan 06, 2020	SELL	$106.92 - $132.43 $8,553 - $10,594	-80 Reduced 0.9%	8,808 $1.16 Million
Q3 2019 Oct 10, 2019	SELL	$106.79 - $116.16 $11,853 - $12,893	-111 Reduced 1.23%	8,888 $994,000
Q2 2019 Jul 15, 2019	BUY	$110.79 - $129.32 $6,868 - $8,017	62 Added 0.69%	8,999 $997,000
Q1 2019 Jun 10, 2019	SELL	$111.31 - $131.02 $7,346 - $8,647	-66 Reduced 0.73%	8,937 $1.16 Million
Q1 2019 May 24, 2019	BUY	$111.31 - $131.02 $101,069 - $118,966	908 Added 11.22%	9,003 $1.04 Million
Q1 2019 Apr 05, 2019	SELL	$111.31 - $131.02 $101,069 - $118,966	-908 Reduced 10.09%	8,095 $1.06 Million
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $6,565 - $7,355	-62 Reduced 0.68%	9,003 $1.04 Million
Q3 2018 Oct 10, 2018	SELL	$85.86 - $107.31 $6,868 - $8,584	-80 Reduced 0.87%	9,065 $973,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $63,890 - $73,326	-844 Reduced 8.45%	9,145 $780,000
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $483,107 - $570,276	-6,510 Reduced 39.46%	9,989 $773,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $5,899 - $6,328	72 Added 0.44%	16,499 $1.39 Million
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $1.27 Million - $1.41 Million	16,427	16,427 $1.41 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account